simulates natural daylight with no UV-rays and enables the dermatologist to dose and control the irradiation of patients with actinic keratosis in a targeted way. The treatment takes place in a specially equipped PDT room in the dermatologist’s practice under the supervision of the practice staff and the treating dermatologist. The possibility of permanent dosimetry and the simultaneous treatment of a variable number of patients are further advantages of this therapy.
With IndoorLux©, SWISS RED AG has developed a fresh new concept in stimulated daylight PDT (SDL-PDT). Just as NDL-PDT, SDL-PDT convinces with its high effectiveness and excellent tolerability. This was impressively substantiated by a retrospective clinical study involving 32 patients with AK 4.
4 BrJ Dermatol 2015 Apr; 172 (4):1146-8.